Leukotrien A4 hydrolase and the committed step in leukotriene B4 biosynthesis-Reference-Cited by-同舟云学术

Leukotrien A4 hydrolase and the committed step in leukotriene B4 biosynthesis

Published:1999-03 Issue:1-2 Volume:17 Page:111-131
ISSN:1080-0549
Container-title:Clinical Reviews in Allergy & Immunology
language:en
Short-container-title:Clinic Rev Allerg Immunol

Author:

Haeggström Jesper Z.

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/BF02737600.pdf

Reference87 articles.

1. Samuelsson B. Leukotrienes: Mediators of immediate hypersensitivity reactions and inflammation. Science 1983;220:568–575.

2. Lewis RA, Austen KF, Soberman RJ. Leukotrienes and other products of the 5-lipoxygenase pathway. New Engl J Med 1990;323:645–655.

3. Borgeat P, Samuelsson B. Arachidonic acid metabolism in polymorphonuclear leukocytes: Unstable intermediate in formation of dihydroxy acids. Proc Natl Acad Sci USA 1979;76:32,133–32,217.

4. Serhan CN, Haeggstrom JZ, Leslie CC. Lipid mediator networks in cells signaling—update and impact of cytokines. FASEB J 1996;10:1147–1158.

5. Haeggstrom J, Radmark O, Fitzpatrick FA. Leukotriene A4-hydrolase activity in guinea pig and human liver. Biochim Biophys Acta 1985;835:378–384.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure-Guided Elaboration of a Fragment-Like Hit into an Orally Efficacious Leukotriene A4 Hydrolase Inhibitor;Journal of Medicinal Chemistry;2024-03-13

2. LTA4H inhibitor LYS006: Clinical PK/PD and safety in a randomized phase I clinical trial;Clinical and Translational Science;2024-02

3. Bioactive lipid regulation of platelet function, hemostasis, and thrombosis;Pharmacology & Therapeutics;2023-06

4. An inhibitor of leukotriene-A ₄ hydrolase from bat salivary glands facilitates virus infection;Proceedings of the National Academy of Sciences;2022-03

5. Drug discovery strategies for novel leukotriene A4 hydrolase inhibitors;Expert Opinion on Drug Discovery;2021-07-16